Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pilar Solves

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Mycoses|January 12, 2019
Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipientsRebeca Rodríguez-Veiga, Pau Montesinos, Estefanía García, et al.
Bone Marrow Transplantation|June 25, 2024
Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experienceMiguel Ángel Sanz, Juan Montoro, Aitana Balaguer-Roselló, et al.
Transplantation and Cellular Therapy|September 14, 2025
Bacterial Bloodstream Infections After Hematopoietic Cell Transplantation With Post-Transplant CyclophosphamidePedro Chorão, Santiago de Cossio, Paula Muñoz-Brell, et al.
Bone Marrow Transplantation|April 24, 2025
Cytokine release syndrome: implications for transplant outcomes in haploidentical and HLA-matched HSCT using PTCyRafael Benavente, Juan Montoro, Aitana Balaguer-Roselló, et al.
Haematologica|September 4, 2025
Genetic risk classification in acute myeloid leukemia patients treated with hematopoietic cell transplantation and post-transplant cyclophosphamideMarta Villalba, Juan Montoro, Aitana Balaguer-Roselló, et al.
Transplantation and Cellular Therapy|July 11, 2025
Mold Invasive Fungal Infection in Hematopoietic Cell Transplant With Post-Transplant Cyclophosphamide and Posaconazole ProphylaxisPedro Chorão, Pablo Granados, Pilar Calvillo-Batllés, et al.
European Journal of Haematology|October 7, 2020
Ex vivo T-cell depletion vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft-vs-host disease prophylaxis for allogeneic hematopoietic stem cell transplantationJuan Montoro, Elisa Roldán, José Luis Piñana, et al.
Transplantation and Cellular Therapy|March 11, 2025
Infectious Enterocolitis in Hematopoietic Cell Transplant with Post-Transplant CyclophosphamidePedro Chorão, André Airosa Pardal, Santiago de Cossio, et al.
Annals of Hematology|June 27, 2019
Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxisRebeca Rodríguez-Veiga, Pau Montesinos, Blanca Boluda, et al.
Journal of Clinical Apheresis|May 8, 2021
Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in SpainBlanca Boluda, Antonio Solana-Altabella, Isabel Cano, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Mycoses|January 12, 2019
Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipientsRebeca Rodríguez-Veiga, Pau Montesinos, Estefanía García, et al.
Bone Marrow Transplantation|June 25, 2024
Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experienceMiguel Ángel Sanz, Juan Montoro, Aitana Balaguer-Roselló, et al.
Transplantation and Cellular Therapy|September 14, 2025
Bacterial Bloodstream Infections After Hematopoietic Cell Transplantation With Post-Transplant CyclophosphamidePedro Chorão, Santiago de Cossio, Paula Muñoz-Brell, et al.
Bone Marrow Transplantation|April 24, 2025
Cytokine release syndrome: implications for transplant outcomes in haploidentical and HLA-matched HSCT using PTCyRafael Benavente, Juan Montoro, Aitana Balaguer-Roselló, et al.
Haematologica|September 4, 2025
Genetic risk classification in acute myeloid leukemia patients treated with hematopoietic cell transplantation and post-transplant cyclophosphamideMarta Villalba, Juan Montoro, Aitana Balaguer-Roselló, et al.
Transplantation and Cellular Therapy|July 11, 2025
Mold Invasive Fungal Infection in Hematopoietic Cell Transplant With Post-Transplant Cyclophosphamide and Posaconazole ProphylaxisPedro Chorão, Pablo Granados, Pilar Calvillo-Batllés, et al.
European Journal of Haematology|October 7, 2020
Ex vivo T-cell depletion vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft-vs-host disease prophylaxis for allogeneic hematopoietic stem cell transplantationJuan Montoro, Elisa Roldán, José Luis Piñana, et al.
Transplantation and Cellular Therapy|March 11, 2025
Infectious Enterocolitis in Hematopoietic Cell Transplant with Post-Transplant CyclophosphamidePedro Chorão, André Airosa Pardal, Santiago de Cossio, et al.
Annals of Hematology|June 27, 2019
Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxisRebeca Rodríguez-Veiga, Pau Montesinos, Blanca Boluda, et al.
Journal of Clinical Apheresis|May 8, 2021
Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in SpainBlanca Boluda, Antonio Solana-Altabella, Isabel Cano, et al.
Pageof 7